GT Medical Technologies Named as “Fierce 15” Company of 2019 by FierceMedTech
What makes GT Medical fierce: In a clinical trial of people with brain tumors, including high-grade gliomas, meningiomas and metastases, the GammaTile implant increased overall survival and delayed the median time to cancer recurrence by nearly 10 additional months, compared to the patients’ previous therapies.